Pregnancy Prevention in Adolescents



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2004 Oct 15;70(8):1517-1524.

  Related Editorial

Although the pregnancy rate in adolescents has declined steadily in the past 10 years, it remains a major public health problem with lasting repercussions for the teenage mothers, their infants and families, and society as a whole. Successful strategies to prevent adolescent pregnancy include community programs to improve social development, responsible sexual behavior education, and improved contraceptive counseling and delivery. Many of these strategies are implemented at the family and community level. The family physician plays a key role by engaging adolescent patients in confidential, open, and nonthreatening discussions of reproductive health, responsible sexual behavior (including condom use to prevent sexually transmitted diseases), and contraceptive use (including the use of emergency contraception). This dialogue should begin before initial sexual activity and continue throughout the adolescent years.

Each year in the United States, approximately 1 million adolescents, or 10 percent of females 15 to 19 years of age, become pregnant.1 These pregnancies, which account for 13 percent of all births, usually are unintended and occur outside of marriage.2 Since 1991, the adolescent pregnancy rate in the United States has fallen by 25 percent, from 116 to 87 per 1,000 females 15 to 19 years of age.3 This decline has been attributed to delayed initiation of sexual intercourse, increased use of contraception, and education about human immunodeficiency virus transmission and pregnancy prevention.4,5 Despite the decline, adolescent pregnancy remains a major public health problem with lasting repercussions.

Strength of Recommendations

Key clinical recommendation Label References

Physicians should link prevention of pregnancy and prevention of sexually transmitted diseases when counseling sexually active teenagers.

C

32,45

Condom use should be encouraged in all sexually active teenagers, regardless of whether another contraceptive method is used.

C

37

Periodic counseling about effective contraceptive methods is recommended for all women at risk for unintended pregnancy.

C

32,45

Strength of Recommendations

View Table

Strength of Recommendations

Key clinical recommendation Label References

Physicians should link prevention of pregnancy and prevention of sexually transmitted diseases when counseling sexually active teenagers.

C

32,45

Condom use should be encouraged in all sexually active teenagers, regardless of whether another contraceptive method is used.

C

37

Periodic counseling about effective contraceptive methods is recommended for all women at risk for unintended pregnancy.

C

32,45

In 2001, the U.S. Surgeon General presented “The Surgeon General’s Call to Action to Promote Sexual Health and Responsible Sexual Behavior,”6 which discussed the need for a national dialogue on this topic, expanding research into sexual health, and improving health care access and social interventions to increase responsible sexual behaviors.

Impact of Teenage Pregnancy

Compared with nonpregnant adolescents, teenage mothers are less likely to graduate from high school and are more likely to score below average in language and reading skills.7,8 These teenagers also are more likely to have low self-esteem and symptoms of depression.9,10 Many of them have behavior and substance-abuse problems and lack the resources to fully foster the emotional development and enrichment of their children’s lives.1113

Children of adolescent mothers are at greater risk of preterm birth, low birth weight, child abuse, neglect, poverty, and death.1417 They are more likely to have behavior disorders and difficulties in school, and to engage in substance abuse.18,19 In 1996, the poverty rate among children born to teenage mothers was 42 percent, twice that of the overall rate in children.20 The infant mortality rate (i.e., deaths in infants younger than one year per 1,000 live births) is higher in children of teenage mothers than in other children.21

All Americans are affected by adolescent pregnancy. The Annie E. Casey Foundation22 reports that more than 75 percent of teenage mothers receive public assistance within five years of delivering their first child. The societal cost of caring for these mothers and their children, including medical expenses, food and housing support, employment training, and foster care, is estimated at $7 billion per year.20

Strategies for Prevention

Many prevention programs are designed to reduce the number of adolescent pregnancies and sexually transmitted diseases (STDs) in the United States. In general, these programs aim to improve the use of contraception and to modify the high-risk behaviors associated with teenage pregnancy and STDs.

YOUTH SOCIAL DEVELOPMENT

Youth social development programs target social and psychologic skills that are necessary to avoid high-risk behaviors such as early sexual activity. These programs operate on the premise that adolescents who delay sexual activity have high educational aspirations, peers with similar norms, and parent-child relationships characterized by supervision, support, and open communication.23

The Seattle Social Development Project24 is a program designed to increase students’ social skills and attachment to school and family. Eighteen elementary schools were assigned to receive intensive training or the usual education curriculum. In the intensive training arm, teachers and parents received annual training in proactive classroom management, problem-solving skills, child behavior management, and drug use prevention in adolescents. The intervention did not include sex education.

Follow-up of 93 percent of the 349 participants at 21 years showed that students in the intervention group had their first sexual experience later than students in the control group (16.3 years versus 15.8 years; P < .05), fewer lifetime sex partners (3.6 versus 4.1; P < .05), and fewer pregnancies (38 percent versus 56 percent; P < .05). These differences were greater in black and female participants.

In the Children’s Aid Society–Carrera Program,25 600 disadvantaged New York City adolescents 13 to 15 years of age were assigned randomly to a typical after-school program or one with a comprehensive youth development curriculum. Follow-up of 79 percent of participants at three years showed that the girls in the intervention group had lower odds of being sexually active (odds ratio [OR], 0.5; P < .05) and of having been pregnant (OR, 0.3; P < .05). Participation in the program had no impact on boys’ sexual and reproductive behavior.

The Teen Outreach Program (TOP),26 another social development program, focuses on volunteer activities. In one evaluation of TOP, 695 high school students from diverse backgrounds were randomized by classroom to TOP or no intervention. Program participants had lower self-reported rates of teen pregnancy, school failure, course failure, and school suspension at one year. The program’s success might be a result of mentorship as well as increasing self-esteem through volunteerism.

ABSTINENCE-ONLY PROGRAMS

Abstinence-only programs teach that abstinence is the only certain way to avoid unmarried pregnancy, STDs, and associated health problems; they may not teach about, endorse, or promote contraception use.27 Such programs became increasingly common after 1996, when Congress allocated $87.5 million per year for distribution to states providing abstinence-only education.

One of the largest and most rigorous studies of abstinence-only programs evaluated the Postponing Sexual Involvement (PSI) program in 31 California counties.28 PSI is a five-session program taught by trained adults or teenagers. A total of 7,340 students with varied racial backgrounds were assigned randomly to intervention or control groups and were followed for up to 17 months. There was no significant difference in pre- and post-intervention self-reported scores on the initiation of sex, frequency of sex, number of sex partners, use of condoms and other birth-control methods, or reported pregnancy rates.

Studies of other abstinence-only programs also have failed to show significant improvement in self-reported rates of intercourse or pregnancy.29 However, the evidence is inconclusive because most of the published studies have major design weaknesses (e.g., small sample size, no comparison group, nonrandom assignment, high attrition rate, inadequate follow-up). Results of larger, more rigorous studies are expected. Mathematica Policy Research, Inc., and the University of Pennsylvania are conducting an independent, federally funded review of Title V Abstinence Education Programs. These reviews have found that, in 700 programs nationwide, most participants report positive feelings about their program experience. Results showing the impact on teenage pregnancy rates are expected in 2005.

COMPREHENSIVE SEX-EDUCATION PROGRAMS

Comprehensive sex-education curricula present abstinence as the most effective method of preventing pregnancy and STDs but also discuss contraception as the appropriate strategy for persons who are sexually active. A review29 of 28 well-designed experimental studies found that most comprehensive sex-education programs do not adversely affect the initiation or frequency of sexual activity, the number of sex partners, or the reported use of condoms and other contraceptive methods. In fact, many programs were shown to significantly improve these outcomes.

Successful programs vary in their approach. Program characteristics that are important in reducing risky sexual behaviors by teenagers are summarized in Table 1.29

TABLE 1

Characteristics of Effective Programs to Reduce Adolescent Sexual Risk-Taking Behaviors

Focus on reducing high-risk sexual behaviors.

Present accurate, age-appropriate, and culturally sensitive information about the risks associated with unprotected sexual activity, use of contraceptives, and strategies for prevention of pregnancy and sexually transmitted infections.

Actively involve all participants.

Allow adequate time for interactive exchange.

Teach communication skills necessary to avoid social pressures that may influence sexual activity.

Apply theoretic models that have proved effective in changing high-risk behaviors, such as social influence theory or cognitive-behavior theory.


Adapted from Kirby D. Emerging answers: research findings on programs to reduce teen pregnancy. Washington, D.C.: National Campaign to Prevent Teen Pregnancy, 2001:10.

TABLE 1   Characteristics of Effective Programs to Reduce Adolescent Sexual Risk-Taking Behaviors

View Table

TABLE 1

Characteristics of Effective Programs to Reduce Adolescent Sexual Risk-Taking Behaviors

Focus on reducing high-risk sexual behaviors.

Present accurate, age-appropriate, and culturally sensitive information about the risks associated with unprotected sexual activity, use of contraceptives, and strategies for prevention of pregnancy and sexually transmitted infections.

Actively involve all participants.

Allow adequate time for interactive exchange.

Teach communication skills necessary to avoid social pressures that may influence sexual activity.

Apply theoretic models that have proved effective in changing high-risk behaviors, such as social influence theory or cognitive-behavior theory.


Adapted from Kirby D. Emerging answers: research findings on programs to reduce teen pregnancy. Washington, D.C.: National Campaign to Prevent Teen Pregnancy, 2001:10.

SEX AND CONTRACEPTIVE COUNSELING

Health care professionals can play a key role in improving contraception use and STD prevention. Success in this regard could have a profound impact on teenage pregnancy rates: the pregnancy rate is 85 percent among young couples who are sexually active for one year without using contraception, and 15 to 30 percent of sexually active teenagers do not use contraception.30

The American Academy of Family Physicians (AAFP),31 the American Academy of Pediatrics (AAP),32 and the American Medical Association (AMA)33  advise physicians to provide adolescents with guidance on sexuality and sexual decision making. Physicians are encouraged to engage all young people—boys and girls—in open, nonjudgmental, and confidential discussions during regular office visits. Counseling should include complete and medically accurate information on responsible sexual behavior. These proactive conversations should begin early and continue throughout a patient’s adolescence. A model for talking to teenagers about responsible sexual behavior is summarized in Table 2.34

TABLE 2

Talking to Teenagers About Responsible Sexual Behavior and Contraception

Engage adolescents in confidential, open, and nonjudgmental discussions independent of caregivers.

Progress to an open discussion about sexual behaviors and concerns.

 “Are there kids your age who have started dating? Have you?”

 “Some girls and boys your age have begun to have sex while others have decided to wait until they are older. How do you feel about it?”

Ask and advise all adolescents about contraception and prevention of sexually transmitted infections.

 “What concerns do you have about getting pregnant? If you would like, we can discuss different kinds of birth control.”

Ask about the relationship between the patient and the parents, and about their views on dating and sexual activity.

 “Would you like to talk about these subjects with me and your parents?”


Information from reference34.

TABLE 2   Talking to Teenagers About Responsible Sexual Behavior and Contraception

View Table

TABLE 2

Talking to Teenagers About Responsible Sexual Behavior and Contraception

Engage adolescents in confidential, open, and nonjudgmental discussions independent of caregivers.

Progress to an open discussion about sexual behaviors and concerns.

 “Are there kids your age who have started dating? Have you?”

 “Some girls and boys your age have begun to have sex while others have decided to wait until they are older. How do you feel about it?”

Ask and advise all adolescents about contraception and prevention of sexually transmitted infections.

 “What concerns do you have about getting pregnant? If you would like, we can discuss different kinds of birth control.”

Ask about the relationship between the patient and the parents, and about their views on dating and sexual activity.

 “Would you like to talk about these subjects with me and your parents?”


Information from reference34.

Family members are encouraged to be actively involved in sex education efforts, because an adolescent’s values and sense of sexual responsibility are influenced by family norms and expectations. However, to maintain confidential and open discussions, the AAFP and AAP recommend that physicians offer adolescent patients the opportunity to have their examination and counseling sessions separate from their parents and guardians, while still encouraging adolescents to involve their caregivers in health care decisions.31,32

The Society for Adolescent Medicine35 defines confidentiality as “an agreement between patient and provider that information discussed during or after the encounter will not be shared with other parties without the explicit permission of the patient.” That organization, along with the AAFP, AAP, and AMA,3133,35 recommends informing adolescents and their parents about the requirements and limits of confidentiality, because some patients may refuse to give accurate medical information without it. Each state has different laws about confidentiality and consent for adolescent health care, and physicians should be familiar with local regulations.36

The AAFP, AAP, and AMA also advise physicians to stress abstinence as the only certain way to prevent pregnancy and STDs.3133 However, if an adolescent chooses to become sexually active, he or she must be counseled on appropriate contraceptive options, and condom use should be encouraged regardless of whether another contraceptive method is used.37 Because condom failure that leads to pregnancy generally is due to improper and inconsistent use, and not defects or breakage,38 providing adolescents with confidential access to condoms and education on consistent and proper use is a priority.

Many effective contraceptive methods are available (Table 3).3941 Discussing common misconceptions, side effects, and other benefits of contraceptives in simple, age-appropriate terms may improve adherence to a chosen contraceptive plan.42 A history, pregnancy test (if indicated), and blood pressure reading are adequate to begin hormonal contraception. The pelvic examination may be deferred until a later visit.43 The American Cancer Society44 now recommends that cervical cancer screening be delayed until three years after the onset of vaginal intercourse or no later than 21 years of age. The Centers for Disease Control and Prevention45 recommends that all sexually active women 25 years of age and younger undergo annual screening for chlamydial infection.

TABLE 3

Contraceptive Options for Adolescents

Failure rate (%)
Method Perfect use* Typical use Dosing Potential side effects Advantages

Male latex condom

3

14

Every act of intercourse

Latex allergy

Recommended to be used in addition to another contraceptive; only method that decreases STD, HIV risk

Combination OCP

0.1

5

Daily

Breakthrough bleeding, nausea, headaches, breast tenderness

Decrease in: PID risk, ectopic pregnancy risk, menstrual blood loss, dysmenorrhea, acne

Progestin-only OCP

0.5

5

Daily (within 3-hour period)

Irregular bleeding, breast tenderness, depression

No estrogen‡ Decrease in: menstrual blood loss, dysmenorrhea

Combination contraceptive patch (Ortho Evra)

0.7

0.9

Weekly for 3 weeks (off on 4th week)

Breakthrough bleeding, nausea, headaches, breast tenderness, skin site reaction, less effective if patient is >90 kg (198 lb)

Similar to OCPs but less frequent dosing

Combined hormonal vaginal ring (NuvaRing)

0.65

N/A

Monthly (insert for 3 weeks of each month)

Vaginal irritation, vaginal discharge, headache

Similar to OCPs but less frequent dosing

Progestin-only injection (Depo-Provera)

0.3

0.3

3 months

Irregular bleeding or amenorrhea, weight gain, breast tenderness, acne, depression, possible decrease in bone density

No estrogen‡ Decrease in: menstrual blood loss, dysmenorrhea, PID risk

Copper-containing intrauterine device (ParaGard)

0.6

0.8

10 years

Heavier menses, dysmenorrhea

Easy to use, long-acting, nonhormonal

Levonorgestrel intrauterine system (Mirena)

0.1

0.1

5 years

Breakthrough bleeding in first 3 to 6 months, then hypo- or amenorrhea

No estrogen‡, easy to use, long-acting Decrease in: menstrual blood loss, dysmenorrhea, (possible) PID risk§

Combined hormonal monthly injection (Lunelle) ||

0.1

N/A

Monthly

Breakthrough bleeding, nausea, headaches, breast tenderness

Better cycle control and quicker return to fertility than progestin-only injection

Single-rod contraceptive implant (Implanon)||

0 to 0.2

N/A

3 years

Irregular bleeding or amenorrhea, weight gain, breast tenderness, acne, depression

No estrogen‡, easy to use, long-acting Decrease in: menstrual blood loss, dysmenorrhea, PID risk


STD = sexually transmitted disease; HIV = human immunodeficiency virus; OCP = oral contraceptive pill; PID = pelvic inflammatory disease.

*— Percentage of couples who initiate and use a method perfectly who experience an accidental pregnancy within the first year of use.

†— Percentage of couples who initiate and use a contraceptive method typically, who experience an accidental pregnancy within the first year of use.

‡— Progestin-only formulations may be beneficial in women with atypical migraine headaches or other conditions associated with estrogen intolerance.

§— PID risk may increase in the first 20 days after insertion.

||— This device is not currently available in the United States; it is being reviewed by the U.S Food and Drug Administration.

Information from references 39 through 41.

TABLE 3   Contraceptive Options for Adolescents

View Table

TABLE 3

Contraceptive Options for Adolescents

Failure rate (%)
Method Perfect use* Typical use Dosing Potential side effects Advantages

Male latex condom

3

14

Every act of intercourse

Latex allergy

Recommended to be used in addition to another contraceptive; only method that decreases STD, HIV risk

Combination OCP

0.1

5

Daily

Breakthrough bleeding, nausea, headaches, breast tenderness

Decrease in: PID risk, ectopic pregnancy risk, menstrual blood loss, dysmenorrhea, acne

Progestin-only OCP

0.5

5

Daily (within 3-hour period)

Irregular bleeding, breast tenderness, depression

No estrogen‡ Decrease in: menstrual blood loss, dysmenorrhea

Combination contraceptive patch (Ortho Evra)

0.7

0.9

Weekly for 3 weeks (off on 4th week)

Breakthrough bleeding, nausea, headaches, breast tenderness, skin site reaction, less effective if patient is >90 kg (198 lb)

Similar to OCPs but less frequent dosing

Combined hormonal vaginal ring (NuvaRing)

0.65

N/A

Monthly (insert for 3 weeks of each month)

Vaginal irritation, vaginal discharge, headache

Similar to OCPs but less frequent dosing

Progestin-only injection (Depo-Provera)

0.3

0.3

3 months

Irregular bleeding or amenorrhea, weight gain, breast tenderness, acne, depression, possible decrease in bone density

No estrogen‡ Decrease in: menstrual blood loss, dysmenorrhea, PID risk

Copper-containing intrauterine device (ParaGard)

0.6

0.8

10 years

Heavier menses, dysmenorrhea

Easy to use, long-acting, nonhormonal

Levonorgestrel intrauterine system (Mirena)

0.1

0.1

5 years

Breakthrough bleeding in first 3 to 6 months, then hypo- or amenorrhea

No estrogen‡, easy to use, long-acting Decrease in: menstrual blood loss, dysmenorrhea, (possible) PID risk§

Combined hormonal monthly injection (Lunelle) ||

0.1

N/A

Monthly

Breakthrough bleeding, nausea, headaches, breast tenderness

Better cycle control and quicker return to fertility than progestin-only injection

Single-rod contraceptive implant (Implanon)||

0 to 0.2

N/A

3 years

Irregular bleeding or amenorrhea, weight gain, breast tenderness, acne, depression

No estrogen‡, easy to use, long-acting Decrease in: menstrual blood loss, dysmenorrhea, PID risk


STD = sexually transmitted disease; HIV = human immunodeficiency virus; OCP = oral contraceptive pill; PID = pelvic inflammatory disease.

*— Percentage of couples who initiate and use a method perfectly who experience an accidental pregnancy within the first year of use.

†— Percentage of couples who initiate and use a contraceptive method typically, who experience an accidental pregnancy within the first year of use.

‡— Progestin-only formulations may be beneficial in women with atypical migraine headaches or other conditions associated with estrogen intolerance.

§— PID risk may increase in the first 20 days after insertion.

||— This device is not currently available in the United States; it is being reviewed by the U.S Food and Drug Administration.

Information from references 39 through 41.

Once the adolescent chooses a contraceptive and STD prevention plan, the AAP recommends intermittent screening for high-risk behaviors and STDs, and frequent monitoring of the patient’s satisfaction with and ability to adhere to the plan.33 Contraception adherence should be discussed at each visit, emphasizing the plan for missed or delayed doses (if the patient is using hormonal contraceptives), and whether modifications to the plan are needed.

In addition to encouraging appropriate contraceptive use and STD prevention, the AAP advises physicians to educate all sexually active adolescents about the availability and use of emergency contraception.33 Counseling should emphasize that emergency contraception is intended only for emergency use, is not as effective in preventing pregnancy as regularly used hormonal methods, and does not protect against the transmission of STDs. However, emergency contraception is safe and effective, and does not act as an abortifacient.46 Advance supply of emergency contraception is associated with increased knowledge and use, without adversely affecting the use of routine contraception.47  Various emergency contraception options are summarized in Table 4.46

TABLE 4

Emergency Contraception Methods

Method Dosage Time interval* Reported efficacy (%)

Combination oral contraceptives

Two doses of 100 mcg of ethinyl estradiol plus 0.5 mg of levonorgestrel (Plan B), taken 12 hours apart

72 hours

75 to 80

Levonorgestrel

Two doses of 0.75 mg, taken 12 hours apart,

72 hours

75 to 80

   or

One dose of 1.5 mg

Copper intrauterine device (ParaGard)

120 hours

99


*— Recommended time interval for use after intercourse for maximal effect.

Information from reference 46.

TABLE 4   Emergency Contraception Methods

View Table

TABLE 4

Emergency Contraception Methods

Method Dosage Time interval* Reported efficacy (%)

Combination oral contraceptives

Two doses of 100 mcg of ethinyl estradiol plus 0.5 mg of levonorgestrel (Plan B), taken 12 hours apart

72 hours

75 to 80

Levonorgestrel

Two doses of 0.75 mg, taken 12 hours apart,

72 hours

75 to 80

   or

One dose of 1.5 mg

Copper intrauterine device (ParaGard)

120 hours

99


*— Recommended time interval for use after intercourse for maximal effect.

Information from reference 46.

COUNSELING MALE ADOLESCENTS

Teenage boys typically experience first intercourse at a younger age and have more sex partners than teenage girls, yet they seek care for reproductive concerns less frequently.48,49 Most adolescent health clinics and education programs target the health of girls, with fewer interventions aimed at boys. A 1993 survey of publicly funded family planning clinics indicated that only 6 percent of patients were male.50 Adolescent boys desire information about STDs, contraception, pregnancy, and sexual health, but as few as 32 percent of sexually active boys receive this information from their health care providers.50 Decreasing the incidence of teenage pregnancy will require focused attention on male adolescents, including establishing avenues for routine sexual health services and targeted educational programs.

Results from the National Survey of Adolescent Males in 1995 indicated that nearly 67 percent of teenage boys used condoms during their most recent act of intercourse. Overall, however, only 69 percent of teenage males used condoms consistently.49 Knowledge about condoms and contraceptives does not appear to encourage initial or consistent use.51 For an adolescent boy, the primary motivating factors for condom use include not only pregnancy and STD prevention, but also partner desires, his perception of his ability to use condoms (“condom use self-efficacy”), and peer perceptions about condoms.52

Guidelines

Several medical organizations endorse efforts to prevent teenage pregnancy and STDs. These guidelines are summarized in Table 5 and serve as a model for family physicians’ roles in teenage pregnancy and STD prevention.3133,37

TABLE 5

Guidelines for Prevention of Pregnancy and Sexually Transmitted Diseases

Recommendation AAFP AAP AMA

Annual visits

X

X

X

Emphasize patient confidentiality during each clinic visit

X

X

X

Obtain history, including:

 Drug and alcohol use

X

 Gynecologic/obstetric history

X

 Medications

X

 Previous and current contraception use

X

X

 Previous STDs

X

X

 Sexual history (number of sex partners, sexual orientation, consensual sex, abuse)

X

X

X

Counseling

 Emphasize that abstinence is priority

X

X

X

 Pregnancy prevention

X

X

X

 Sexuality education

X

X

X

 STD prevention

X

X

X

Discuss contraception

X

X

X

 Condoms

X

X

X

 Other methods

X

X

X

 Emergency postcoital contraception

X

Emphasize adolescent male responsibility in preventing pregnancy and STDs

X

Encourage parental involvement

X

X

X

Support and participate in ongoing research

X

Support condom-use campaigns

X

Support community outreach programs

X

X


AAFP = American Academy of Family Physicians; AAP = American Academy of Pediatrics; AMA = American Medical Association; STDs = sexually transmitted diseases.

Information from references 31 throug h33, and 37.

TABLE 5   Guidelines for Prevention of Pregnancy and Sexually Transmitted Diseases

View Table

TABLE 5

Guidelines for Prevention of Pregnancy and Sexually Transmitted Diseases

Recommendation AAFP AAP AMA

Annual visits

X

X

X

Emphasize patient confidentiality during each clinic visit

X

X

X

Obtain history, including:

 Drug and alcohol use

X

 Gynecologic/obstetric history

X

 Medications

X

 Previous and current contraception use

X

X

 Previous STDs

X

X

 Sexual history (number of sex partners, sexual orientation, consensual sex, abuse)

X

X

X

Counseling

 Emphasize that abstinence is priority

X

X

X

 Pregnancy prevention

X

X

X

 Sexuality education

X

X

X

 STD prevention

X

X

X

Discuss contraception

X

X

X

 Condoms

X

X

X

 Other methods

X

X

X

 Emergency postcoital contraception

X

Emphasize adolescent male responsibility in preventing pregnancy and STDs

X

Encourage parental involvement

X

X

X

Support and participate in ongoing research

X

Support condom-use campaigns

X

Support community outreach programs

X

X


AAFP = American Academy of Family Physicians; AAP = American Academy of Pediatrics; AMA = American Medical Association; STDs = sexually transmitted diseases.

Information from references 31 throug h33, and 37.

The Authors

SAWSAN AS-SANIE, M.D., M.P.H., is an obstetrician-gynecologist and a Triangle Clinical Research Fellow in reproductive health at the University of North Carolina School of Medicine, Chapel Hill, where she received a master’s degree in public health in epidemiology. Dr. As-Sanie received her medical degree from the Johns Hopkins University School of Medicine, Baltimore, and completed clinical training at MetroHealth Medical Center, Cleveland, Ohio, and the Cleveland Clinic Foundation.

ANGELA GANTT, M.D., M.P.H., is an obstetrician-gynecologist and an assistant professor at the University of North Carolina School of Medicine, where she received her medical degree and a master’s degree in public health in health care and prevention. Dr. Gantt completed clinical training at the Ohio State University School of Medicine, Columbus.

MARJORIE S. ROSENTHAL, M.D., is a pediatrician and Robert Wood Johnson Clinical Scholar in the Division of Community Pediatrics at Yale University School of Medicine, New Haven, Conn., where she received her medical degree. Dr. Rosenthal completed clinical training at the Johns Hopkins University School of Medicine.

Address correspondence to Sawsan As-Sanie, M.D., M.P.H., Department of Obstetrics and Gynecology, University of North Carolina-Chapel Hill, CB#7570, MacNider Building, Chapel Hill, NC 27599-7570 (e-mail: suzieassanie@yahoo.com). Reprints are not available from the authors.

The authors indicate that they do not have any conflicts of interest. Sources of funding: none reported.

REFERENCES

1. National and state-specific pregnancy rates among adolescents—United States, 1995–1997. MMWR Morb Mortal Wkly Rep. 2000;49:952–3.

2. Ventura SJ, Mathews TJ, Curtin SC. Declines in teenage birth rates, 1991–98: update of national and state trends. Natl Vital Stat Rep. 1999;47:1–9.

3. Ventura SJ, Abma JC, Mosher WD, Henshaw S. Revised pregnancy rates, 1990–97, and new rates for 1998–99: United States. Natl Vital Stat Rep. 2003;52:1–14.

4. Trends in sexual risk behaviors among high school students—United States, 1991–2001.. MMWR Morb Mortal Wkly Rep. 2002;51:856–9.

5. Research on today’s issues. Less sexual activity, more education, changes in contraception key to declining teen birth rates. Accessed online August 26, 2004, at: http://www.nichd.nih.gov/cpr/dbs/pubs/ti10.pdf.

6. The Surgeon General’s call to action to promote sexual health and responsible sexual behavior. June 2001. Accessed online August 25, 2004, at: http://www.surgeongeneral.gov/library/sexualhealth/call.htm.

7. Hofferth SL, Reid L, Mott FL. The effects of early child-bearing on schooling over time. Fam Plann Perspect. 2001;33:259–67.

8. Rauch-Elnekave H. Teenage motherhood: its relationship to undetected learning problems. Adolescence. 1994;29:91–103.

9. Koniak-Griffin D, Walker DS, de Traversay J. Predictors of depression symptoms in pregnant adolescents. J Perinatology. 1996;16:69–76.

10. Barnet B, Joffe A, Duggan AK, Wilson MD, Repke JT. Depressive symptoms, stress, and social support in pregnant and postpartum adolescents. Arch Pediatr Adolesc Med. 1996;150:64–9.

11. Barnet B, Duggan AK, Wilson MD, Joffe A. Association between postpartum substance use and depressive symptoms, stress, and social support in adolescent mothers. Pediatrics. 1995;96;(4 pt 1):659–66.

12. Leadbeater BJ, Bishop SJ. Predictors of behavior problems in preschool children of inner-city Afro-American and Puerto Rican adolescent mothers. Child Dev. 1994;65;(2 spec no):638–48.

13. Gilchrist LD, Hussey JM, Gillmore MR, Lohr MJ, Morrison DM. Drug use among adolescent mothers: pre-pregnancy to 18 months postpartum. J Adolesc Health. 1996;19:337–44.

14. Jolly MC, Sebire N, Harris J, Robinson S, Regan L. Obstetric risks of pregnancy in women less than 18 years old. Obstet Gynecol. 2000;96:962–6.

15. Fraser AM, Brockert JE, Ward RH. Association of young maternal age with adverse reproductive outcomes. N Engl J Med. 1995;332:1113–7.

16. Siegel CD, Graves P, Maloney K, Norris JM, Calonge BN, Lezotte D. Mortality from intentional and unintentional injury among infants of young mothers in Colorado, 1986 to 1992. Arch Pediatr Adolesc Med. 1996;150:1077–83.

17. Overpeck MD, Brenner RA, Trumble AC, Trifiletti LB, Berendes HW. Risk factors for infant homicide in the United States. N Engl J Med. 1998;339:1211–6.

18. Fergusson DM, Woodward LJ. Maternal age and educational and psychosocial outcomes in early adulthood. J Child Psychol Psychiatry. 1999;40:479–89.

19. Fergusson DM, Lynskey MT. Maternal age and cognitive and behavioural outcomes in middle childhood. Paediatr Perinat Epidemiol. 1993;7:77–91.

20. Maynard RA. Kids having kids: economic costs and social consequences of teen pregnancy. Washington, D.C.: Urban Institute Press, 1997.

21. MacDorman MF, Atkinson JO. Infant mortality statistics from the 1997 period linked birth/infant death data set. Natl Vital Stat Rep. 1999;47:1–23.

22. When teens have sex: issues and trends. A Kids Count special report. Accessed online August 25, 2004, at: http://www.aecf.org/kidscount/teen.

23. Carrera MA. Preventing adolescent pregnancy: in hot pursuit. SIECUS Rep. 1995;23:16–9.

24. Lonczak HS, Abbott RD, Hawkins JD, Kosterman R, Catalano RF. Effects of the Seattle social development project on sexual behavior, pregnancy, birth, and sexually transmitted disease outcomes by age 21 years. Arch Pediatr Adolesc Med. 2002;156:438–47.

25. Philliber S, Kaye JW, Herrling S, West E. Preventing pregnancy and improving health care access among teenagers: an evaluation of the children’s aid society-carrera program. Perspect Sex Reprod Health. 2002;34:244–51.

26. Allen JP, Philliber S, Herrling S, Kuperminc GP. Preventing teen pregnancy and academic failure: experimental evaluation of a developmentally based approach. Child Dev. 1997;68:729–42.

27. The evaluation of abstinence education programs funded under Title V, Section 510. Accessed online August 25, 2004, at: http://www.mathematica-mpr.com/welfare/abstinence.asp.

28. Kirby D, Korpi M, Barth RP, Cagampang HH. The impact of the Postponing Sexual Involvement curriculum among youths in California. Fam Plann Perspect. 1997;29:100–8.

29. Kirby D. Emerging answers: research findings on programs to reduce teen pregnancy. Washington, D.C.: National Campaign to Prevent Teen Pregnancy, 2001.

30. Everett SA, Warren CW, Santelli JS, Kann L, Collins JL, Kolbe LJ. Use of birth control pills, condoms, and withdrawal among U.S. high school students. J Adolesc Health. 2000;27:112–8.

31. American Academy of Family Physicians. Policy and advocacy: adolescent health care. Accessed online August 25, 2004, at: http://www.aafp.org/x6613.xml.

32. Felice ME, Feinstein RA, Fisher M, Kaplan DW, Olmedo LF, Rome ES, et al. American Academy of Pediatrics. Committee on Adolescence. Contraception in adolescents. Pediatrics. 1999;105;(5 pt 1):1161–6.

33. The American Medical Association. Guidelines for adolescent preventive services (GAPS). Accessed online August 25, 2004, at: http://www.ama-assn.org/ama/pub/category/1980.html.

34. Kaunitz AM. Contraception for the adolescent patient. Int J Fertil Womens Med. 1997;42:30–8.

35. Sigman G, Silber TJ, English A, Epner JE. Confidential health care for adolescents: position paper of the Society for Adolescent Medicine. J Adolesc Health. 1997;21:408–15.

36. Boonstra H, Nash E. Issues in brief. Minors and the right to consent to health care. Accessed online August 25, 2004, at: http://www.guttmacher.org/pubs/ib_minors_00.html.

37. Kaplan DW, Feinstein RA, Fisher MM, Klein JD, Olmedo LF, Rome ES, et al. Condom use by adolescents. Pediatrics. 2001;107:1463–9.

38. Crosby RA, Sanders SA, Yarber WL, Graham CA, Dodge B. Condom use errors and problems among college men. Sex Transm Dis. 2002;29:552–7.

39. Perlman SE, Richmond DM, Sabatini MM, Krueger H, Rudy SJ. Contraception. Myths, facts, and methods. J Reprod Med. 2001;46;(2 suppl):169–77.

40. Burkman RT. The transdermal contraceptive patch: a new approach to hormonal contraception. Int J Fertil Womens Med. 2002;47:69–76.

41. Roumen FJ, Apter D, Mulders TM, Dieben TO. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod. 2001;16:469–75.

42. Mauldon J, Luker K. The effects of contraceptive education on method use at first intercourse. Fam Plann Perspect. 1996;28:19–24.

43. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. JAMA. 2001;285:2232–9.

44. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342–62.

45. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51;(RR-6):1–78.

46. Glasier A. Emergency postcoital contraception. N Engl J Med. 1997;337:1058–64.

47. Jackson RA, Bimla Schwarz E, Freedman L, Darney P. Advance supply of emergency contraception. Effect on use and usual contraception—a randomized trial. Obstet Gynecol. 2003;102:8–16.

48. U.S. Teenage pregnancy statistics: overall trends, trends by race and ethnicity and state-by-state information. Accessed online August 25, 2004, at: http://www.agi-usa.org/pubs/teen_preg_stats.html.

49. Sonenstein FL, Ku L, Lindberg LD, Turner CF, Pleck JH. Changes in sexual behavior and condom use among teenaged males: 1988 to 1995. Am J Public Health. 1998;88:956–9.

50. Watt LD. Pregnancy prevention in primary care for adolescent males. J Pediatr Health Care. 2001;15:223–8.

51. Hiltabiddle SJ. Adolescent condom use, the health belief model, and the prevention of sexually transmitted disease. J Obstet Gynecol Neonatal Nurs. 1996;25:61–6.

52. Sieving R, Resnick MD, Bearinger L, Remafedi G, Taylor BA, Harmon B. Cognitive and behavioral predictors of sexually transmitted disease risk behavior among sexually active adolescents. Arch Pediatr Adolesc Med. 1997;151:243–51.



Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Download PDF
  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in Pubmed

Navigate this Article